MedTech News
.................... by Andrew Celentano

Fecal transplant can improve response to immunotherapy in advanced kidney cancer
An Italian study published in Nature Medicine provides compelling evidence that fecal microbiota transplantation (FMT) can enhance the effectiveness of immunotherapy in patients with advanced metastatic renal cell carcinoma (mRCC).

Glowing bacterial sensors detect gut illness in mice before symptoms emerge
University of British Columbia researchers have engineered gut bacteria that dim their fluorescent glow in the presence of illness. Their findings could improve how we diagnose problems in the gut by using bacteria that already live there. The work appears in Cell.

No more jet lag? Scientists discover oral compound that helps ‘reset’ the body clock forward
A Japanese research team has discovered a new compound that can advance the body’s internal clock—offering hope for faster recovery from jet lag and better adaptation to night-shift work.

DNA research uncovers 22 genes that could put people at risk of long-term health conditions
Baylor College of Medicine researchers are part of a collaborative research group with AstraZeneca and Memorial Sloan Kettering Cancer Center that have identified 22 genes which increase the risk of developing a range of chronic conditions following a common viral infection.

Targeting the gut’s immune system could tackle early stages of Parkinson’s
New research reveals how Parkinson’s spreads from the gut to the brain, with the help of immune cells—offering a new potential therapeutic strategy—in a study in mice led by scientists at the UK Dementia Research Institute at UCL (University College London).

Fecal transplant capsules show promising results in clinical trials for multiple types of cancer
Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in the Nature Medicine journal.

New nanotherapy eases bone metastasis pain by disrupting tumor-nerve crosstalk
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it’s needed is here to improve the precision and comfort of cancer therapy.

Glaukos gets FDA nod for iDose TR re-administration
Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR system.